Estimates Revisions Thor Medical Nasdaq Stockholm
Stocks
NANOVO
NO0010597883
Biotechnology & Medical Research
|
Market Closed -
Nasdaq Stockholm
19:00:00 25/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.565 NOK | -2.87% |
|
0.00% | -8.02% |
| 08-28 | Thor Medical ASA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-28 | Thor Medical ASA, H1 2026 Earnings Call, Aug 28, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Thor Medical(NANOV)
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- NANOV Stock
- NANOVO Stock
- Consensus Thor Medical
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
